NJ ACTS Pilot Program 2024
The 2024 pilot program is designed to propel clinical and translational science initiatives throughout NJ ACTS, engaging our academic alliance partners (Rutgers, Princeton, and New Jersey Institute of Technology) and our health system partner, RWJ Barnabas Health.
Our initiative seeks to furnish initial resources aimed at nurturing programs that can then vie competitively for expanded extramural support, leveraging funding opportunities such as Element E or RC2 (see RFA for explanation) studies pertinent to NJ ACTS or through independent extramural avenues (R or K series grants).
Total funding support may not exceed $40,000 for 6-9 months.
|